0001264931-20-000257.txt : 20201217 0001264931-20-000257.hdr.sgml : 20201217 20201217090030 ACCESSION NUMBER: 0001264931-20-000257 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201217 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jupiter Wellness, Inc. CENTRAL INDEX KEY: 0001760903 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 832455880 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39569 FILM NUMBER: 201394393 BUSINESS ADDRESS: STREET 1: 725 N. HWY A1A STREET 2: SUITE C-106 CITY: JUPITER STATE: FL ZIP: 33458 BUSINESS PHONE: 561-325-0482 MAIL ADDRESS: STREET 1: 725 N. HWY A1A STREET 2: SUITE C-106 CITY: JUPITER STATE: FL ZIP: 33458 FORMER COMPANY: FORMER CONFORMED NAME: CBD Brands, Inc. DATE OF NAME CHANGE: 20181206 8-K 1 jupw8k121720.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 17, 2020

 

JUPITER WELLNESS, INC.

(Exact name of registrant as specified in charter)

 

Delaware   001-39569   83-2455880
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

725 N. Hwy A1A, Suite C-106 Jupiter, FL 33477

(Address of principal executive offices) (Zip Code)

 

(561) 244-7100

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   JUPW  

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Warrants, each exercisable for one share of Common Stock at $8.50 per share   JUPWW  

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 Item 7.01 Regulation FD Disclosure

 

On December 17, 2020, Jupiter Wellness, Inc. issued the attached press release. A copy of the press release is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibits

 

Exhibit No.   Description
      99.1   Press release, dated December 17, 2020

 

 1 
   

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 17, 2020

 

  JUPITER WELLNESS, INC.
   
  By: /s/ Brian John
    Brian John
    Chief Executive Officer

 

 2 
   

 

EX-99 2 ex99_1.htm PRESS RELEASE, DATED DECEMBER 17, 2020

Jupiter Wellness at the Surf Expo 2021 in Orlando January 6-8 to

Exhibit CaniSun Suncare Product Line.

 

Patent-pending innovative CBD-infused reef-friendly SPF sunscreen formulations.

 

Jupiter, FL – Accesswire - December X, 2020 - Jupiter Wellness, Inc. (Nasdaq: JUPW), a leading developer of innovative skin care products, lotions, medical therapeutics and wellness products, today announced they will exhibit at SURF EXPO 2021, January 6-8, at the Orange County Convention Center in Orlando, Florida Booth #709.

 

Surf Expo is the largest and longest running watersports, beach and resort lifestyle tradeshow in the world. The show historically draws an average of more than 28,000 buyers from specialty stores, major chains, resorts, cruise lines, marinas and beach rental companies from across the US, Caribbean, Central & South America.

 

Jupiter Wellness owns the Canisun brand, an innovative patent pending line of suncare products infused with CBD. CBD, which has been clinically shown to protect the viability of skin cells from ultraviolet B (UVB) irradiation in a study published in the peer reviewed Journal of Cosmetic Dermatology. Surf Expo provides targeted expansion of distribution channels for Jupiter Wellness and helps build on the recent SRM Entertainment acquisition and their established vendor relationships with global theme parks and resorts.

 

“Canisun CBD infused Suncare Products will be on display at Surf Expo along with our recently published skin cell study and the clinical study that we just announced on November 24th for the treatment of actinic keratosis (AK), the most common precancer that forms on the skin as a result of exposure to UV rays. “Surf Expo, provides a great opportunity to meet buyers and expand distribution”. stated Brian John CEO of Jupiter Wellness.

 

For additional information on Surf Expo, please visit: https://www.surfexpo.com/the-show/j20-highlights/.

 

About Jupiter Wellness
Jupiter Wellness, Inc. (NASDAQ: JUPW) is a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products. The Company’s clinical pipeline of prescription CBD-enhanced skin care therapeutics address indications including eczema, burns, herpes cold sores, and skin cancer. Jupiter generates revenues from a growing line of proprietary over-the-counter skincare products including its flagship CaniSun™ sunscreen and other wellness brands sold through its distribution platform.

 

For additional information, please visit www.jupiterwellnessinc.com. The Company’s public filings can be found at www.Sec.gov.

 

Safe Harbor Statement
To the extent any statements contained in this presentation of Jupiter Wellness, Inc. (the “Company”) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 and the information that are based upon beliefs of, and information currently available to, the company’s management as well as estimates and assumptions made by the company’s management. These statements can be identified by the fact that they do not relate strictly to historic or current facts. When used in this presentation the words “estimate,” “expect,” intend,” believe,” plan,” “anticipate,” “projected” and other words or the negative of these terms and similar expressions as they relate to the company or the company’s management identify forward-looking statements. Such statements reflect the current view of the company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the company’s industry, its operations and results of operations and any businesses that may be acquired by the company. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, the company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Investor & Public Relations Contact Info

Phone: 561-244-7100

Email: info@jupiterwellnessinc.com